Advocacy News

The Academy submitted comments to regional Medicare contractors last week defending coverage of MIGS, cataract surgery, and botulinum toxin injections.  

The 2025 Medicare Physician-Fee Schedule proposes significant changes to the Merit-Based Incentive Payment System cost performance category which may affect your score in the current and future performance year.

Ravi Goel, MD explains why all ophthalmologists should check their inbox for the AMA's practice expense survey.

The proposed rule for 2025 Medicare payment rates for hospital outpatient and ambulatory surgical centers includes a 2.6% payment bump.

We underscored our opposition to the new requirements in the finalized Eyeglass Rule and urged the commission to extend the implementation deadline to Jan. 1, 2025.

Although the Federal Trade Commission did not scrap the proposal, Academy advocacy resulted in meaningful flexibility for meeting new requirements.

Eligible clinicians can preview their 2023 Merit-Based Incentive Payment System (MIPS) final performance scores now that the Centers for Medicare & Medicaid Services has opened them for review. Final scores determine clinicians’ 2025 payment adjustments.

The Department of Health and Human Services (HHS) has issued a final rule which includes a significant penalty on Merit-Based Incentive Payment System (MIPS) for providers found to knowingly commit information blocking.

Pediatric ophthalmologists working in medically underserved areas with student loan debts have until July 9 to apply for loan relief through the Health Resource and Services Administration Pediatric Specialty Loan Repayment Program, which provides up to $100,000 in assistance. 

Academy member physicians presented coverage recommendations this week to medical directors for the CGS, NGS, and Palmetto Medicare jurisdictions for both minimally invasive glaucoma surgery (MIGS) and medical botulinum toxin injections.